Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
USA Catalog
INFECTIOUS DISEASES - EBV
LIAISON® EBV IgM |
310500 |
Intended use |
For the qualitative determination of IgM antibodies to Epstein-Barr Virus. |
Material provided |
Reagent Integral for 100 determinations. Diluent included. |
Method |
2-step chemiluminescent immunoassay using directly coated magnetic microparticles. |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum |
LIAISON® VCA IgG |
310510 |
Intended use |
For the qualitative determination of IgG antibodies to Epstein-Barr Virus Viral Capsid Antigen (VCA). |
Material provided |
Reagent Integral for 100 determinations. Diluent included. |
Method |
2-step chemiluminescent immunoassay using directly coated magnetic microparticles. |
Calibrators |
included |
Incubations |
20 min |
Sample type |
Serum |
LIAISON® EBNA IgG |
310520 |
Intended use |
For the qualitative deterination of IgG antibodies to Epstein-Barr Virus Nuclear Antigen (EBNA-1). |
Material provided |
Reagent Integral for 100 determinations. Diluent included. |
Method |
2-step chemiluminescent immunoassy using directly coated magnetic microparticles. |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum |
LIAISON® EA IgG |
310540 |
Intended use |
For the qualitative determination of IgG antibodies to Epstein-Barr Virus Early Antigen (Diffuse) (EA). |
Material provided |
Reagent integral for 100 determinations. Diluent included. |
Method |
2-step chemiluminescent immunoassay using directly coated magnetic microparticles. |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum |